Upregulation of IKK2 and IκBs in c-Rel+ GCB-DLBCL may contribute to the decreased p53 levels in GCB-DLBCL (Fig. 3D) [41]. This evidence concerns the gene TP53 and diffuse large B-cell lymphoma.